Detalles de la búsqueda
1.
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
Nat Immunol
; 23(1): 40-49, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34937928
2.
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Nat Immunol
; 22(5): 620-626, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33674800
3.
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Nat Immunol
; 22(7): 928, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34017126
4.
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
N Engl J Med
; 386(13): 1207-1220, 2022 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172051
5.
Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021.
Euro Surveill
; 27(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34991777
6.
Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK.
Emerg Infect Dis
; 27(7): 1795-1801, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34152947
7.
HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in London.
Sex Transm Infect
; 97(5): 382-386, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33361466
8.
Plans for Nationwide Serosurveillance Network in Vietnam.
Emerg Infect Dis
; 26(1)2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31855527
9.
Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16.
Euro Surveill
; 24(1)2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30621818
10.
Influenza vaccination during the 2021/22 season: A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients.
Vaccine
; 42(7): 1656-1664, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342716
11.
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024.
JMIR Public Health Surveill
; 10: e52047, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38569175
12.
Reassurance of population immunity to diphtheria in England: Results from a 2021 national serosurvey.
Vaccine
; 2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37821313
13.
Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study.
J Infect
; 87(5): 420-427, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37689394
14.
Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study.
Pediatr Infect Dis J
; 42(6): 496-502, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36916856
15.
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.
Nat Commun
; 14(1): 5948, 2023 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741831
16.
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
J Infect
; 87(4): 315-327, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37579793
17.
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.
iScience
; 26(12): 108500, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089581
18.
Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action.
J Antimicrob Chemother
; 67(7): 1589-96, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22532463
19.
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.
Microbiol Spectr
; 10(1): e0228921, 2022 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35196807
20.
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups.
J Infect
; 84(5): 675-683, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990709